TY - JOUR 
AU - Ariza Lozano, Juan Guillermo
AU - Thuresson MPharm, Per-Olof
AU - Machnicki, Gerardo
AU - Mungapen, Laura
AU - Kraemer, Matthias
AU - Asukai, Yumi
AU - Giraldo Cadavid, Luis Fernando
PY - 2012
UR - http://hdl.handle.net/10818/36812
AB - Objectives
The main objectives were to estimate the cost-effectiveness and budget impact of indacaterol (a once-daily, long-acting-beta2-agonist) compared with 1) salmeterol/fluticasone, 2) formoterol/budesonide, and 3) tiotropium for the treatment of...
LA - eng
PB - Value in Health Regional
KW - COPD
KW - Cost-effectiveness
KW - Indacaterol
KW - Colombia
TI - The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System
T2 - The Cost Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System
DO - 10.1016/j.vhri.2012.09.003
ER -